Angioedema market examined in new market research report

The purpose of the report is to illustrate the state of the market of Angioedema, to present actual information about the volumes of production, exports, imports, consumption and the state of the market, the changes that took place in 2017, and also, to build a forecast for the growth of the industry in the medium term until 2026.

Market Insights:

Growth in healthcare investments, prevalence of angioedema and growing high-risk geriatric population are the major factors driving the global market growth for angioedema treatment. North America is the largest regional market at a market share of over 41% in 2015, and the dominance of this region is anticipated to continue through 2022. Rising incidence of angioedema and high awareness about treatment and the management of angioedema together drive the North America angioedema market. Asia Pacific is expected to be the fastest growing market in the global angioedema market due to rising prevalence rate in the countries like Japan, China and others. Moreover, the growing research and development in the drug discovery of angioedema would further drive the market during the forecast period.

The treatment types include Antihistamines, Corticosteroids, Autoimmune drugs, antifibrinolytic agents and blood protein controllers. Antihistamines and Corticosteroids accounted for approximately 45% – 50% of the total market share because these are the first line therapies preferred by the medical practitioners and majorly used as supportive therapies and most accessible source of treatment across the globe. Despite the high cost of new treatment options in comparison to older therapies such as attenuated androgens and antifibrinolytic agents, they are popular with physicians due to the superior control offered over symptoms such as subcutaneous and abdominal swelling. These highly priced drugs have therefore managed to capture a high prescription share. Hence, introduction of new drugs with further improved effectiveness and safety will drive the global angioedema market during the forecast period.

Leading Players: AstraZeneca plc , Hoffmann-La Roche AG, Valeant Pharmaceuticals International, Merck & Co., Dyax Corp, CSL Behring,

Browse here for full report with Toc: https://www.credenceresearch.com/report/angioedema-treatment-market

Why was the report written?
This report is the result of an extensive survey drawn from Credence Research’s exclusive panel of leading global market industry executives; it provides data and analysis on buyer investment, acquisition, and developments within the global market research. It includes key topics such as global Angioedema buyer expenditure and procurement behaviors and strategies and recognizes the threats and possibilities within the industry, economic outlook trends, and business confidence within global industry executives. Most secondary research reports are based on general industry drivers and do not understand the industry executives’ attitude and changing behaviors, creating a gap in presenting the business outlook of the industry; in an effort to bridge this gap, Credence Research created this primary research-based report by gathering the opinions of multiple stakeholders in the value chain of the global industry.

What is the current market landscape and what is changing?
Executives from the global industry anticipate an increase in levels of consolidation, with 55% of respondents projecting an increase in merger and acquisition (M&A) activities in 2017.
The report on the market of Angioedema contains:
Analysis and forecast of Angioedema market dynamics;
Analysis of domestic production, market shares of the main market players;
Analysis of exports and imports;
Analysis of factors, leading the development of the Angioedema market;
Assessment and forecast of Angioedema market development;
Financial and business profiles of the leading companies in the Angioedema industry.

Scope
– Up to date working Angioedema data by major regions in the world, the forecast of planned capacity additions by 2026
– The annual breakdown of capital expenditure spending on proposed Angioedema for the period 2018 to 2026
– Planned Angioedema additions and capital expenditure spending by key countries and companies across the world
– Planned capital expenditure spending on new Angioedema projects by region, key countries, and companies
– Details of major planned Angioedema projects in the world up to 2026

Browse here for full report with Toc: https://www.credenceresearch.com/report/angioedema-treatment-market
Also you can request us for sample in pdf with more details and graph: https://www.credenceresearch.com/sample-request/58017

About Us
Credence Research is a worldwide market research and counseling firm that serves driving organizations, governments, non-legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Over almost a century, we’ve manufactured a firm extraordinarily prepared to this task.

Contact Us:
Credence Research Inc.
105 N 1st ST #429
SAN JOSE
CA 95103
United States
Toll Free (US/CANADA): +1-800-361-8290
Web: https://www.credenceresearch.com

Be the first to comment

Leave a Reply

Your email address will not be published.


*